EBF1 is only deregulated in lung cancer, but only in two of the ten datasets, while RUNX1 is deregulated in lung cancer and breast cancer, but its regulation varies: it is positive in some datasets and negative in others of the same type of cancer. Here, EBF1 is linked to breast cancer.